Showing 6511-6520 of 8649 results for "".
- BioTime Announces $1.9 Million Grant for Continued Development of OpRegen for Dry-AMDhttps://modernod.com/news/biotime-announces-1-9-million-grant-for-continued-development-of-opregen-for-dry-amd/2480136/BioTime has been awarded a new grant for 2018 of up to 6.9 million Israeli New Shekels (approximately $1.9 million) from the Israel Innovation Authority (IIA). The grant provides funding for the continued development of OpRegen, and to date the IIA has provided annual grants totaling over $13 mil
- Optovue Announces Retirement of Industry Veteran John Hawleyhttps://modernod.com/news/optovue-announces-retirement-of-industry-veteran-john-hawley/2480137/Optovue announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales. Mr. Hawley will retire on July 1, 2018, and remain with Optovue in an advisory role. “For the past 10 years, I have worked side-by-side with John as we built Opto
- Wize Pharma Announces Presentation of New Data on LO2A in the Treatment of Dry Eye Syndrome in Patients with Sjögren’s Syndromehttps://modernod.com/news/wize-pharma-announces-presentation-of-new-data-on-lo2a-in-the-treatment-of-dry-eye-syndrome-in-patients-with-sjogrens-syndrome/2480143/Wize Pharma announced recently reported new data on a formula known as LO2A, a product that Wize has in-licensed certain rights to purchase, market, sell and distribute. The poster presentation presented at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting
- Telescope Implant for End-State Macular Degeneration Now on the Federal Supply Schedule and Available at VA Hospitalshttps://modernod.com/news/telescope-implant-for-end-state-macular-degeneration-now-on-the-federal-supply-schedule-and-available-at-va-hospitals/2480149/VisionCare announced that MellingMedical will distribute the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to Department of Veteran’s Affairs hospitals, military hospitals, and other federal government healthcare facilities in the United States. MellingMedical provides medical su
- Moorfields Eye Hospital Dubai in Collaboration with Moorfields Eye Hospital Abu Dhabi Develop Procedure to Diagnose Retinal Problems in Childrenhttps://modernod.com/news/moorfields-eye-hospital-dubai-in-collaboration-with-moorfields-eye-hospital-abu-dhabi-develop-procedure-to-diagnose-retinal-problems-in-children/2480152/A medical study on diagnosing children undertaken in the United Arab Emirates by a team of four consultants at Moorfields Eye Hospital Dubai and Moorfields Eye Hospital Abu Dhabi has achieved the distinction of becoming the first medical study undertaken entirely in the UA
- Study Compares the Accuracy of Subjective Refraction Using a Vmax Vision’s VASR vs. Traditional Refractionhttps://modernod.com/news/study-compares-the-accuracy-of-subjective-refraction-using-a-vmax-visions-vasr-vs-traditional-refraction/2480157/A comparison study reported at ARVO 2018, conducted by Drs. Christopher Lievens, Christina Newman, Alan Kabat, and optometry student Jacob Weber at the Southern College of Optometry (SCO), included 50 healthy subjects
- Retinal Changes on OCT Angiography May Flag Early Alzheimer’shttps://modernod.com/news/retinal-changes-on-oct-angiography-may-flag-early-alzheimers/2480158/Microvascular changes in the retina detected by using noninvasive optical coherence tomography (OCT) angiography align well with imaging and biomarker evidence of preclinical Alzheimer’s disease, a new study shows, according to a Medscape
- Eye Health America Appoints Cathleen McCabe, MD, as Chief Medical Officerhttps://modernod.com/news/eye-health-america-appoints-cathleen-mccabe-md-as-chief-medical-officer/2480162/Eye Health America (EHA) has appointed Cathleen McCabe, MD, as its chief medical officer. As the newest member of EHA’s executive leadership team, Dr. McCabe will be responsible for the development, implementation, and continuation of best practices across EHA’s group practices and ambulatory sur
- Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globallyhttps://modernod.com/news/alcon-cares-project-100-commits-to-reducing-cataract-blindness-globally/2480168/Alcon announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phaco surgeries. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 rep
- Sylentis Announces New Data on the Treatment of Allergic Conjunctivitishttps://modernod.com/news/sylentis-announces-new-data-on-the-treatment-of-allergic-conjunctivitis/2480172/At the ARVO meeting, Sylentis presented preclinical results on its RNAi therapy, demonstrating how SYL116011 acts on seasonal ocular allergies SYL116011, which is being researched for ocular allergies caused by pollen, reduces the symptoms related to allergy, such as swelling and tearing,